amantadine has been researched along with chlordiazepoxide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (27.27) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Anishchenko, GIa; Gruzman, GB | 1 |
| Critchley, E | 1 |
| Fisher, H; Goldberg, M; Mirovsky, Y; Sekowski, A; Wagner, GC; Yu, YL | 1 |
1 review(s) available for amantadine and chlordiazepoxide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
10 other study(ies) available for amantadine and chlordiazepoxide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Benign essential tremor.
Topics: Adolescent; Adult; Aged; Amantadine; Chlordiazepoxide; Ethanol; Female; Humans; Male; Mephenesin; Middle Aged; Parasympatholytics; Posture; Rest; Tremor | 1972 |
[Several features of the course of spastic torticollis].
Topics: Adult; Aged; Amantadine; Brain Diseases; Brain Stem; Cervical Vertebrae; Chlordiazepoxide; Disability Evaluation; Electromyography; Female; Humans; Hyaluronoglucosaminidase; Infections; Male; Massage; Middle Aged; Nerve Block; Osteochondritis; Parasympatholytics; Paresthesia; Radiculopathy; Remission, Spontaneous; Spinal Osteophytosis; Torticollis; Ultrasonic Therapy | 1974 |
Clinical manifestations of essential tremor.
Topics: Adult; Aged; Amantadine; Ataxia; Chlordiazepoxide; Dihydroxyphenylalanine; Female; Humans; Male; Mephenesin; Middle Aged; Movement Disorders; Nerve Degeneration; Parkinson Disease; Sweating; Tremor | 1972 |
Novel synergistic treatment of ethanol withdrawal seizures in rats with dopamine and serotonin agonists.
Topics: Alcohol Withdrawal Delirium; Amantadine; Amphetamine; Animals; Chlordiazepoxide; Dopamine Agonists; Drug Synergism; Drug Therapy, Combination; Fenfluramine; Male; Pyrimidines; Rats; Serotonin Receptor Agonists | 1995 |